Grannus Therapeutics
grannustherapeutics.com
Actively hiring
Biotechnology
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$950k
2 rounds on record
Latest round
$950k
Venture round · Jan 2022 · 4 yr ago
Team
11-50
employees, estimated range
Backers
2
1842 Fund & Studio, Elevate Ventures
The money's age
Long since its last round
56 months since the last round · not hiring
Momentum
0/100
no fresh signals
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Debt Financing | Nov 2023 | $800k | — | SEC Form D |
| Venture round | Jan 2022 | $950k | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Grannus Therapeutics Inc. | sec |
Founders and leadersfrom filings, registers and the company's site
John FoglesongExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
1842 Fund & Studio 
Elevate Ventures Overview
Meet the Grannus leadership team—biotech veterans and oncology innovators united by a mission to deliver smarter, safer, and more effective targeted cancer treatments.
People
John Foglesong
Executive Officer, Director
James Thompson
Director
Brian Blagg
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Indianapolis
United States
HQ
10-50 est. staff